Shares of Transcept Pharmaceuticals (TSPT) soar in premarket trading, up 15.5%, after the firm...

|By:, SA News Editor

Shares of Transcept Pharmaceuticals (TSPT) soar in premarket trading, up 15.5%, after the firm announces privately-held Purdue exercised its option to commercialize Intermezzo in the U.S. with a Q2 launch planned. Purdue will kick in $100M to support sales and marketing of the sleeping disorder treatment during its first year on the market.